Back to all studies
RecruitingNCT06786936

Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms

This recruiting study focuses on depression and currently lists sites or participation links in United Kingdom.

DepressionOtherFrom 18 Years to 74 Years
In plain English

Key information made simple

This study exists to explore whether the medication IL-17 could improve care and understanding. Researchers are trying to understand what the medication IL-17 can reveal about signals in the brain or body that may guide care later on. For people living with Depression, small gains in stability can make a meaningful difference over time. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including Queen Elizabeth University Hospital in Glasgow. Participation appears to center on assessments, scans, or samples rather than trying a new treatment. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include pregnancy or breastfeeding and major medical issues that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT06786936. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in United Kingdom.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com